Hong Kong stocks fluctuate | BeiGene (06160.HK) surges over 4% again, Zeposidin exceeds expectations in the US and European markets.

According to the 36kr Finance and Economics APP, BeiGene Ltd. (06160.HK) has risen by more than 4% again, with an increase of 4.15% as of the time of writing, reaching 205.6 Hong Kong dollars, with a turnover of 2.23 billion Hong Kong dollars.